Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study

Author: Delmas P.   Recker R.   Chesnut C.   Skag A.   Stakkestad J.   Emkey R.   Gilbride J.   Schimmer R.   Christiansen C.  

Publisher: Springer Publishing Company

ISSN: 0937-941X

Source: Osteoporosis International, Vol.15, Iss.10, 2004-10, pp. : 792-798

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content